Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11008316 Glucosylceramide synthase inhibitors

Patent 11008316 was granted and assigned to Genzyme on May, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12083115 Methods for treating neurological symptoms associated with lysosomal storage diseases
0
Edits on 14 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12060349 Glucosylceramide synthase inhibitors
0
Edits on 3 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11857512 Pharmaceutical compositions comprising venglustat
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+345 characters)
Article

Patent abstract

The invention relates to inhibitors of glucosylceramide synthase (GCS), such as Compound of Formula I, shown below, as defined herein, useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.

Edits on 10 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 10 Oct, 2023
Edits made to:
Infobox (+18 properties)
Infobox
Patent Inventor Names
Andrew Good0
Bradford Hirth0
Cassandra Celatka0
Elina Makino0
Elyse Bourque0
Herve Husson0
John Leonard0
John Marshall0
Katherine Jancsics0
Mario A. Cabrera-Salazar0
Markus Metz0
Oxana Beskrovnaya0
Renato Skerlj0
Ronald K. Scheule0
Seng H. Cheng0
Thomas Natoli0
Yibin Xiang0
Zhong Zhao0
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110083160
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Genzyme
Genzyme
0
Current Assignee
Genzyme
Genzyme
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110083160
Date of Patent
May 18, 2021
0
Patent Application Number
154903850
Date Filed
April 18, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110083160
Patent Primary Examiner
‌
Brian E McDowell
0
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11008316
Edits on 11 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 11 Feb, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 11008316 Glucosylceramide synthase inhibitors

Infobox
Is a
Patent
Patent
Patent applicant
Genzyme
Genzyme
Current assignee
Genzyme
Genzyme
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11008316
Date of patent
May 18, 2021
Patent application number
15490385
Date Filed
April 18, 2017
Patent primary examiner
‌
Brian E McDowell

Find more entities like US Patent 11008316 Glucosylceramide synthase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo